Novartis Continues Portfolio Revamp With $420M Elidel Sale - WSJ.com

Links shared publicly online about this topic.

  • 383
    total visits

Novartis Continues Portfolio Revamp With $420M Elidel Sale - WSJ.com

online.wsj.com

Novartis Continues Portfolio Revamp With $420M Elidel Sale - WSJ.com

View full resource at online.wsj.com

Tags: Novartis

  • Share

Most Recently Shared on April 7, 2011 at 12:10 pm By:

organic_beauty_ Shalona Anuj, PhD

Novartis Continues Portfolio Revamp With $420M Elidel Sale http://bit.ly/hIsqRc

1 year ago...

Advertisement